GL1X · GenesisL1 explorer

MolNFT v1 · #122745 · protein

Protruding domain of GII.4 human norovirus CHDC2094 in complex with hbga type a (triglycan)

5IYP · VP1: “Protruding domain of GII.4 human norovirus CHDC2094 in complex with hbga type a (triglycan)”. X-ray diffraction, 3 ligands (GLA, FUC, A2G), 7 pockets (best druggability 0.69). MolNFT v1 #122745 on GenesisL1: 3D structure…

PDB
5IYP
Type
protein
Length
609 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
VP1
UniProt
D0QJ68
Ligands
GLA, FUC, A2G
Pockets
7 · best druggability 0.69

Structure

x-ray diffraction · 2 distinct chains · 7% helix, 36% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AVP1protein3037% helix, 36% strandD0QJ68
BVP1protein3067% helix, 36% strandD0QJ68

Ligands and binding sites

  • GLA · alpha-D-galactopyranose · sugar · 2 copies · chains B, A
  • FUC · alpha-L-fucopyranose · sugar · 2 copies · chains A, B
  • A2G · 2-acetamido-2-deoxy-alpha-D-galactopyranose · sugar · 2 copies · chains A, B
  • EDO · 1,2-ethanediol · additive · 7 copies · chains A, B
  • FLC · Citrate anion · additive · chains B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

7 pockets found on a 1 Å grid, 6 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1510.690.9820empty
21750.660.8635EDO
32690.630.8133empty
42420.600.8030EDO
52040.560.7930empty

Interfaces

1 interface between chains.

  • A–B · 1906 Ų buried · 25 hydrogen bonds · protein-protein

Compared structures

  • 5IYP · Protruding domain of GII.4 human norovirus CHDC2094 in complex with HBGA type A… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.